Pfizer Inc. (NYSE:PFE) is one of the dividend stocks picked by financial media as investors ask whether dividend stocks are tax-efficient. On June 24, Pfizer said its board declared a $0.43 third-quarter dividend on the company's common stock, payable September 1 to holders of record at the close of business on July 24. Pfizer also said the third-quarter cash dividend would be its 351st consecutive quarterly dividend.
The stock is a useful example because dividend tax efficiency should not be confused with dividend safety or business momentum. A regular U.S. corporate dividend may receive qualified-dividend treatment when the shareholder meets holding-period rules, making it more tax-favorable than ordinary income in many cases. But a large or steady cash payout still creates taxable income in the year it is received. Pfizer's dividend record gives the income stream visibility, but the long-term case remains tied to product execution, pipeline progress, debt management, and cash generation. The tax character improves the after-tax profile; it does not remove the need to evaluate the business behind the payout.
Pfizer Inc. (NYSE:PFE) is a biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines.
While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
Yorumlar (0)
Giriş yaparak yorum yazabilirsin.
İlk yorumu sen yaz.